SCHEMBL35282

SCHEMBL35282

C1CC2CCCN2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29190841 0.96
SCHEMBL30952478 0.96
Hydrochloric Acid SCHEMBL10514755 0.96
SCHEMBL29586137 0.96 L3MBTL3 (0.44)
SCHEMBL3232584 0.93
SCHEMBL339598 0.93
SCHEMBL38654566 0.93
SCHEMBL3225027 0.93
SCHEMBL969472 0.93
SCHEMBL6194042 0.90 HTR6 (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 5131 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3906040-B1 COMBINATION OF CIMICIFUGA AND PETASITES EXTRACTS FOR ANTICANCER THERAPY AND PROPHYLAXIS ZELLER MAX SOEHNE AG (CH) 2026-04-08 EP claimed
EP-4216951-B1 KRAS G12D INHIBITORS MIRATI THERAPEUTICS INC (US) 2026-04-01 EP claimed
US-20260070896-A1 HETEROCYCLE DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2026-03-12 US claimed
WO-2026040069-A1 REACTIVE HOT-MELT ADHESIVE COMPOSITION AND USE THEREOF HENKEL AG & CO. KGAA (DE) 2026-02-26 WO claimed
US-20250376469-A1 INDOLIZINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
US-20250376461-A1 INDAZOLE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
US-20250376468-A1 PYRAZOLO[1,5-a]PYRIDINE DERIVATIVES FOR TREATING TRPM3-MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-12-11 US claimed
US-20250346605-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-11-13 US claimed
US-20250346569-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-11-13 US claimed
US-20250320189-A1 NEW DERIVATIVES FOR TREATING TRPM3 MEDIATED DISORDERS UNIV LEUVEN KATH (BE) 2025-10-16 US claimed
EP-0089061-B1 8-SUBSTITUTED PYRROLIZIDINE DERIVATIVES AND USE THEREOF SUNTORY KABUSHIKI KAISHA (JP) 1987-12-16 EP claimed
EP-0213956-A1 Pyrrolizidine pharmaceutical compounds and compositions and their preparation SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 1987-03-11 EP claimed
US-4617401-A ANTISPASMODIC AGENTS, VASODILATORS SUNTORY LTD. (JP) 1986-10-14 US claimed
EP-0039903-B1 8-SUBSTITUTED PYRROLIZIDINES AND QUATERNARY AMMONIUM SALTS THEREOF SUNTORY KABUSHIKI KAISHA (JP) 1986-04-09 EP claimed
EP-0171912-A1 Pyrrolizidine compounds, methods for their production, and their uses SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1986-02-19 EP claimed
EP-0153855-A2 Pyrrolizidine derivative SUNTORY KABUSHIKI KAISHA, also known as SUNTORY LTD. (JP) 1985-09-04 EP claimed
EP-0089061-A2 8-Substituted pyrrolizidine derivatives and use thereof SUNTORY KABUSHIKI KAISHA (JP) 1983-09-21 EP claimed
US-4376776-A Dibenzofuran derivatives and their use for controlling fungi BASF AKTIENGESELLSCHAFT (DE) 1983-03-15 US claimed
US-4327214-A Substituted alkylammonium salts, the manufacture thereof, the use thereof for regulating plant growth, and agents therefor BASF AKTIENGESELLSCHAFT (DE) 1982-04-27 US claimed
EP-0039903-A2 8-Substituted pyrrolizidines and quaternary ammonium salts thereof SUNTORY KABUSHIKI KAISHA (JP) 1981-11-18 EP claimed